Robbins Wendye

DirectorRAPT Therapeutics, Inc. (RAPT) · full profile →Form 4 · filed Mar 15, 2023
Net Buying
Open-Market Buys
$98K
Open-Market Sells
$0
Net Open-Market Flow
$98K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 14, 2023Buy(P)2K$18.75$28K14K
Mar 14, 2023Buy(P)3K$20.05$50K7K
Mar 14, 2023Buy(P)600$19.95$12K15K
Mar 14, 2023Buy(P)400$18.48$7K14K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-019023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.